Literature DB >> 17634862

Non-infectious endophthalmitis associated with trypan blue use in cataract surgery.

Lihteh Wu1, Roberto Velasquez, Olga Montoya.   

Abstract

BACKGROUND: The visualization of the anterior lens capsule is greatly enhanced by trypan blue staining facilitating the creation of a continuous curvilinear capsulorhexis. Trypan blue has been deemed safe in this setting.
METHODS: We report the findings and management of a retrospective interventional case series comprising three eyes that developed non-infectious endophthalmitis following routine trypan blue staining of the anterior lens capsule with the same batch of Vission (0.6 mg/ml) during uncomplicated small incision phacoemulsification of 17 consecutive eyes.
RESULTS: On post-op day 1, 18% had an increased cellular response in the anterior chamber and anterior vitreous precluding fundus visualization, 12% had a hypopyon. Initial visual acuity (VA) ranged from hand motions to light perception. Eyes were initially managed with topical and oral steroids. Two eyes underwent vitrectomy. Vitreous cultures were all negative. One eye had a repeat vitrectomy to remove an epiretinal membrane. Final VA achieved was 20/80, 20/20 and 20/20.
CONCLUSION: Trypan blue may be associated with severe intraocular inflammation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17634862     DOI: 10.1007/s10792-007-9119-9

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  11 in total

1.  Cystoid macular oedema with trypan blue use.

Authors:  P Gouws; M Merriman; S Goethals; P R Simcock; R J Greenwood; G Wright
Journal:  Br J Ophthalmol       Date:  2004-10       Impact factor: 4.638

Review 2.  Toxic anterior segment syndrome.

Authors:  Nick Mamalis; Henry F Edelhauser; Daniel G Dawson; Jesse Chew; Russell M LeBoyer; Liliana Werner
Journal:  J Cataract Refract Surg       Date:  2006-02       Impact factor: 3.351

Review 3.  Capsular staining: recent developments.

Authors:  Faruk Ozturk; Robert H Osher
Journal:  Curr Opin Ophthalmol       Date:  2006-02       Impact factor: 3.761

4.  Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study.

Authors:  D P Han; S R Wisniewski; L A Wilson; M Barza; A K Vine; B H Doft; S F Kelsey
Journal:  Am J Ophthalmol       Date:  1996-07       Impact factor: 5.258

5.  Safety of trypan blue 1% and indocyanine green 0.5% in assisting visualization of anterior capsule during phacoemulsification in mature cataract.

Authors:  Chong Fai Chung; Chan Chung Liang; Jimmy S M Lai; Ernie S F Lo; Dennis S C Lam
Journal:  J Cataract Refract Surg       Date:  2005-05       Impact factor: 3.351

6.  Dye-enhanced cataract surgery. Part 2: learning critical steps of phacoemulsification.

Authors:  L Werner; S K Pandey; M Escobar-Gomez; D S Hoddinott; D J Apple
Journal:  J Cataract Refract Surg       Date:  2000-07       Impact factor: 3.351

7.  Comparison of dyes for cataract surgery. Part 1: cytotoxicity to corneal endothelial cells in a rabbit model.

Authors:  Yi-Sheng Chang; Shih-Ya Tseng; Sung-Huei Tseng; Ying-Ting Chen; Jing-Hsing Hsiao
Journal:  J Cataract Refract Surg       Date:  2005-04       Impact factor: 3.351

Review 8.  Age-related cataract.

Authors:  Penny A Asbell; Ivo Dualan; Joel Mindel; Dan Brocks; Mehdi Ahmad; Seth Epstein
Journal:  Lancet       Date:  2005 Feb 12-18       Impact factor: 79.321

9.  Fungal endophthalmitis following cataract surgery: clinical presentation, microbiological spectrum, and outcome.

Authors:  S Narang; A Gupta; V Gupta; M R Dogra; J Ram; S S Pandav; A Chakrabarti
Journal:  Am J Ophthalmol       Date:  2001-11       Impact factor: 5.258

10.  Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Endophthalmitis Vitrectomy Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1995-12
View more
  1 in total

Review 1.  Trypan blue dye for anterior segment surgeries.

Authors:  V Jhanji; E Chan; S Das; H Zhang; R B Vajpayee
Journal:  Eye (Lond)       Date:  2011-06-17       Impact factor: 3.775

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.